Intellectual Property India Publishes Patent Application for Anti-Transferrin Receptor Antibodies, Conjugates Thereof, And Uses Thereof

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617092572 A) filed by Arrowhead Pharmaceuticals, Inc. on July 30, 2026, for Anti-Transferrin Receptor Antibodies, Conjugates Thereof, And Uses Thereof.

Inventors include Glebocka, Agnieszka; Xu, Zhao; Carlson, Jeffrey; Ye, Jingdong; and Fowler-Watters, Matthew.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The invention provides a transferrin receptor (TfR1) antibody for conjugation to therapeutic payloads. The TfR1 antibodies may be used for delivering the therapeutic payloads, for instance oligonucleotide-based agents, to CNS tissues, skeletal muscle tissues, or heart tissues in vivo.

Discl...